Endonovo Therapeutics, Inc.
General ticker "ENDV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $89.9K (TTM average)
Endonovo Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -18.3%.
Estimated limits based on current volatility of 12.9%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 9 as of 2022
- Top business risk factors: Liquidity and credit risks, Economic downturns and volatility, Internal control weaknesses, Governance risks
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.00$, 0.00$]
- 2025-12-31 to 2026-12-31 estimated range: [0.00$, 0.00$]
Financial Metrics affecting the ENDV estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 38.76 > 13.24
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ENDV quotes
Long-term ENDV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.14MM | $0.14MM | $0.01MM |
| Operating Expenses | $3.40MM | $3.06MM | $1.57MM |
| Operating Income | $-3.26MM | $-2.92MM | $-1.56MM |
| Non-Operating Income | $-15.21MM | $9.84MM | $-1.24MM |
| Interest Expense | $1.32MM | $1.28MM | $1.24MM |
| Income(Loss) | $-18.47MM | $6.92MM | $-2.80MM |
| Profit(Loss)* | $-18.47MM | $6.92MM | $-2.80MM |
| Stockholders Equity | $-32.18MM | $-24.11MM | $-26.80MM |
| Assets | $1.28MM | $0.64MM | $0.02MM |
| Operating Cash Flow | $-0.68MM | $0.12MM | $0.10MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.59MM | $-0.12MM | $-0.11MM |
| Earnings Per Share** | $-0.13 | $0.03 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.